Autoimmune Disease Diagnostics Market - Highlights
Autoimmune disease is a disorder where body’s own immune system starts attacking the healthy cells instead of foreign particles and disease-causing agents. The rising awareness about autoimmune disorders, technological advancement in the healthcare sector and rise in number of cases of autoimmune diseases are the factors driving the growth of the global autoimmune disease diagnostics market. Moreover, strategic collaborations and aggressive strategies by major players are also contributing to the growth of the market. For instance, in May 2018, Myriad Genetics, Inc. has acquired Counsyl, Inc. for USD 375 million, Counsyl is a global leader in genetic testing and personalized medicine segment.
The increasing occurrences of several diseases like rheumatoid arthritis and Hashimoto’s thyroiditis are likely to influence the market across the globe. Several initiatives taken by the government regarding autoimmune disease diagnosis are further contributing to its growth. As per the American Autoimmune Related Diseases Association, approximately 50 million people from America are suffering from autoimmune related disorders. Such factors are likely to create immense opportunities to the growth of autoimmune disease diagnostics market.
On the contrary, the surging false positive results along with the price war among the companies are the top barriers likely to vitiate the market growth to some extent during the appraisal period. Moreover, the dearth of education and experience of the lab personnel in diagnosing certain autoimmune diseases are further estimated to slow down the market growth.
Global Autoimmune Disease Diagnostics Market Segmentation:
The global autoimmune disease diagnostics market has been segmented By
- test type,
- disease type
- end-user.
By mode of disease type, the global autoimmune disease diagnostics market has been segmented into
- systemic autoimmune disease,
- localized autoimmune disease.
Among these, the localized autoimmune disease segment is likely to gain prominence owing to the presence of large procedure volume and higher patient awareness level.
By mode of test type, the global autoimmune disease diagnostics market has been segmented into enzyme-linked immunosorbent assay (ELISA),
- western blotting
- dot blot
- double immune diffusion
- line blot
- counter immune electrophoresis
- multiplex immunoassay
- immunofluorescence assays (IFA)
- agglutination
By mode of end-users, the global autoimmune disease diagnostics market has been segmented into
- diagnostics centers,
- hospitals,
- research laboratories
Competitive Dashboard
The prominent players operating in the global autoimmune disease diagnostics market are
- Siemens Healthcare Private Limited,
- Beckman Coulter Inc.,
- Bio-rad Laboratories,
- EUROIMMUN AG, AstraZeneca,
- Inova Diagnostics Inc.,
- Hoffmann-la Roche,
- Thermo Fisher Scientific,
- Myriad Genetics Inc.,
- Hemagen Diagnostics Inc
- Trinity Biotech Plc.
Autoimmune Disease Diagnostics Market Regional Insights
Geographically, the Autoimmune Disease Diagnostics Market span across regions namely,
- America
- Europe
- Asia-Pacific
America
Considering the global scenario, the American region is predicted to command the maximum share in the global autoimmune disease diagnostics market. The region is likely to retain its pole position owing to the surging prevalence of autoimmune diseases like rheumatoid arthritis. Moreover, the rising financial support by the private organizations and governments coupled with the adoption of high advanced technology in this region is anticipated to contribute to the growth of the market. As per a report published by the Arthritis Foundation in 2017, around 91 million Americans were suffering from arthritis, 300000 of them were children.
Europe
The European region is predicted to occupy the second spot in the global market owing to the increased automation in the laboratories, rising healthcare industry, and strategies implemented by the top market players like mergers & acquisitions and product launches.
Asia-Pacific
The Asia Pacific region is likely to expand at the fastest growth rate during the assessment period. The growth can be ascribed to the inflating population, rising private-public partnerships for the improvement of the healthcare sector, and surging prevalence of autoimmune disorders in this region.
Browse Full Research Report at: https://www.marketresearchfuture.com/reports/autoimmune-disease-diagnostics-market-6715
RELATED REPORTS
Pain Relief Medication Market Research Report - Global Forecast till 2027
Orthopedic Braces Market Research Report - Global Forecast till 2027
Post-Traumatic Stress Disorder (PTSD) Market Research Report - Global Forecast till 2027
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
